Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis
Trabectedin for the Treatment of Advanced Metastatic Soft Tissue Sarcoma: A NICE Single Technology Appraisal
Cabazitaxel for the Second-Line Treatment of Metastatic Hormone-Refractory Prostate Cancer: A NICE Single Technology Appraisal
Disutility of Illness for Caregivers and Families: A Systematic Review of the Literature
Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-Analysis
Simulating Lifetime Outcomes Associated with Complications for People with Type 1 Diabetes
Cost Effectiveness of Targeted High-dose Atorvastatin Therapy Following Genotype Testing in Patients with Acute Coronary Syndrome
A Comment on Craig et al.: ‘‘Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary Generalization: A NICE Single Technology Appraisal''